Liver upregulation of genes involved in cortisol production and action is associated with metabolic syndrome in morbidly obese patients

Obesity Surgery

Volumn 22, Issue 3, 2012, Pages 478-486

  Torrecilla, Esther ^a   Fernández Vázquez, Gumersindo ^a   Vicent, David ^a   Sánchez Franco, Franco ^a   Barabash, Ana ^b   Cabrerizo, Lucio ^b   Sánchez Pernaute, Andrés ^b   Torres, Antonio J ^b   Rubio, Miguel Ángel ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

11 Hydroxysteroid dehydrogenase type 1; Gene expression; Glucocorticoid receptor; Metabolic syndrome; Morbid obesity; Phosphoenolpyruvate carboxykinase

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; GLUCOCORTICOID RECEPTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (PYROPHOSPHATE); TRIACYLGLYCEROL;

11B HSD1 GENE; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE TARGETING; GR GENE; H6PDH GENE; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; LIVER; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; PEPCK GENE; PRIORITY JOURNAL; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; ADULT; BARIATRIC SURGERY; CORTISONE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYDROCORTISONE; LIVER; MALE; METABOLIC SYNDROME X; OBESITY, MORBID; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 84857365181     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-011-0524-9     Document Type: Article

References (44)

1. P Anagnostis VG Athyros K Tziomalos, et al. 2009 Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis J Clin Endocrinol Metab 94 2692 701 19470627 10.1210/jc.2009-0370 1:CAS:528: DC%2BD1MXpvFGnsbo%3D
2. MS Cooper PM Stewart 2009 11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation J Clin Endocrinol Metab 94 4645 54 19837912 10.1210/jc.2009-1412 1:CAS:528:DC%2BD1MXhsFyltLjE
3. JW Tomlinson EA Walker IJ Bujalska, et al. 2004 11β-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response Endocr Rev 25 831 66 15466942 10.1210/er.2003-0031 1:CAS:528:DC%2BD2cXhtVSjtrnJ (Pubitemid 39366049)
4. AG Atanasov LG Nashev RA Schweizer, et al. 2004 Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase FEBS Lett 571 129 33 15280030 10.1016/j.febslet.2004.06.065 1:CAS:528:DC%2BD2cXmtVWjt7c%3D (Pubitemid 38992936)
5. GG Lavery EA Walker N Draper, et al. 2006 Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation J Biol Chem 281 6546 51 16356929 10.1074/jbc.M512635200 1:CAS:528:DC%2BD28XhvFOgs7s%3D (Pubitemid 43847588)
6. Y Kotelevtsev MC Holmes A Burchell, et al. 1997 11Beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress Proc Natl Acad Sci U S A 94 14924 29 9405715 10.1073/pnas.94.26.14924 1:STN:280:DyaK1c%2FntVymtg%3D%3D (Pubitemid 28041476)
7. H Masuzaki J Paterson H Shinyama, et al. 2001 A transgenic model of visceral obesity and the metabolic syndrome Science 294 2166 70 11739957 10.1126/science.1066285 1:CAS:528:DC%2BD3MXptVOmsbs%3D (Pubitemid 33150673)
8. JM Paterson NM Morton C Fievet, et al. 2004 Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice Proc Natl Acad Sci U S A 101 7088 93 15118095 10.1073/pnas.0305524101 1:CAS:528:DC%2BD2cXktFeqsLo%3D (Pubitemid 38596447)
9. M Palermo CH Shackleton F Mantero, et al. 1996 Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man Clin Endocrinol (Oxf). 45 605 11 10.1046/j.1365-2265.1996.00853.x 1:CAS:528:DyaK2sXjt1SgsA%3D%3D (Pubitemid 26411362)
10. PM Stewart AM Wallace SM Atherden, et al. 1990 Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man Clin Sci (Lond). 78 49 54 1:CAS:528:DyaK3cXhtlahsrk%3D (Pubitemid 20030050)
11. PM Stewart A Boulton S Kumar, et al. 1999 Cortisol metabolism in human obesity: impaired cortisone∈→∈cortisol conversion in subjects with central adiposity J Clin Endocrinol Metab 84 1022 7 10084590 10.1210/jc.84.3.1022 1:CAS:528:DyaK1MXhvFegu7Y%3D (Pubitemid 29138237)
12. E Rask T Olsson S Soderberg, et al. 2001 Tissue-specific dysregulation of cortisol metabolism in human obesity J Clin Endocrinol Metab 86 1418 21 11238541 10.1210/jc.86.3.1418 1:CAS:528:DC%2BD3MXitFWnurk%3D (Pubitemid 32323037)
13. E Rask BR Walker S Soderberg, et al. 2002 Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity J Clin Endocrinol Metab 87 3330 6 12107245 10.1210/jc.87.7.3330 1:CAS:528:DC%2BD38XlsVGjurk%3D (Pubitemid 34816385)
14. G Valsamakis A Anwar JW Tomlinson, et al. 2004 11Beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus J Clin Endocrinol Metab 89 4755 61 15356090 10.1210/jc.2003-032240 1:CAS:528:DC%2BD2cXnslWgsr8%3D (Pubitemid 39244498)
15. JW Tomlinson JS Moore PM Clark, et al. 2004 Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue J Clin Endocrinol Metab 89 2711 6 15181046 10.1210/jc.2003-031376 1:CAS:528:DC%2BD2cXmtlGqtbc%3D (Pubitemid 38766354)
16. J Westerbacka H Yki-Jarvinen S Vehkavaara, et al. 2003 Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver J Clin Endocrinol Metab 88 4924 31 14557475 10.1210/jc.2003-030596 1:CAS:528: DC%2BD3sXoslemurk%3D (Pubitemid 37357545)
17. TC Sandeep R Andrew NZ Homer, et al. 2005 Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone Diabetes 54 872 9 15734867 10.2337/diabetes.54.3.872 1:CAS:528:DC%2BD2MXitlegsLc%3D (Pubitemid 40322093)
18. R Desbriere V Vuaroqueaux V Achard, et al. 2006 11Beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients Obesity (Silver Spring). 14 794 8 10.1038/oby.2006.92 1:CAS:528:DC%2BD28XotlKlu7Y%3D (Pubitemid 46219720)
19. B Mariniello V Ronconi S Rilli, et al. 2006 Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome Eur J Endocrinol 155 435 41 16914598 10.1530/eje.1.02228 1:CAS:528:DC%2BD28XhtVClur%2FE (Pubitemid 44463950)
20. A Veilleux C Rheaume M Daris, et al. 2009 Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women J Clin Endocrinol Metab 94 3550 7 19567539 10.1210/jc.2008-2011 1:CAS:528:DC%2BD1MXhtFChtLzI
21. JW Tomlinson B Sinha I Bujalska, et al. 2002 Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity J Clin Endocrinol Metab 87 5630 5 12466364 10.1210/jc.2002-020687 1:CAS:528:DC%2BD38XpslWnurw%3D (Pubitemid 36034370)
22. O Paulmyer-Lacroix S Boullu C Oliver, et al. 2002 Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study J Clin Endocrinol Metab 87 2701 5 12050237 10.1210/jc.87.6.2701 1:CAS:528:DC%2BD38XkvFakt7k%3D (Pubitemid 34655333)
23. K Kannisto KH Pietilainen E Ehrenborg, et al. 2004 Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins J Clin Endocrinol Metab 89 4414 21 15356040 10.1210/jc.2004-0153 1:CAS:528:DC%2BD2cXnslWht74%3D (Pubitemid 39244448)
24. S Engeli J Bohnke M Feldpausch, et al. 2004 Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss Obes Res 12 9 17 14742837 10.1038/oby.2004.3 1:CAS:528:DC%2BD2cXhvVGkt78%3D (Pubitemid 41137482)
25. RS Lindsay DJ Wake S Nair, et al. 2003 Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians J Clin Endocrinol Metab 88 2738 44 12788882 10.1210/jc.2002-030017 1:CAS:528:DC%2BD3sXkslCrsL4%3D (Pubitemid 36724450)
26. G Uckaya N Karadurmus O Kutlu, et al. 2008 Adipose tissue 11-beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase gene expressions are increased in patients with type 2 diabetes mellitus Diabetes Res Clin Pract. 82 Suppl 2 S135 40 18963204 10.1016/j.diabres.2008.09. 022 1:CAS:528:DC%2BD1cXhsVKlsL3L
27. J Koska B de Courten DJ Wake, et al. 2006 11Beta-hydroxysteroid dehydrogenase type 1 in adipose tissue and prospective changes in body weight and insulin resistance Obesity (Silver Spring). 14 1515 22 10.1038/oby.2006.175 1:CAS:528:DC%2BD28Xht1WjsLzM (Pubitemid 46214818)
28. JW Tomlinson J Finney C Gay, et al. 2008 Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity Diabetes 57 2652 60 18633104 10.2337/db08-0495 1:CAS:528:DC%2BD1MXhs1Knsbk%3D
29. R Muñoz C Carvajal A Escalona, et al. 2009 11Beta-hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients Obes Surg 19 764 70 18592327 10.1007/s11695-008-9616-6
30. SM Grundy JI Cleeman SR Daniels, et al. 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 112 2735 52 16157765 10.1161/CIRCULATIONAHA.105.169404 (Pubitemid 41532612)
31. Y Iwasaki S Takayasu M Nishiyama, et al. 2008 Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene Mol Cell Endocrinol 285 10 8 18313835 10.1016/j.mce.2008.01.012 1:CAS:528:DC%2BD1cXivFOqsr0%3D
32. Y Liu Y Nakagawa Y Wang, et al. 2005 Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice Diabetes 54 32 40 15616008 10.2337/diabetes.54.1.32 1:CAS:528:DC%2BD2MXhtVWjur0%3D (Pubitemid 40105092)
33. NM Morton V Densmore M Wamil, et al. 2005 A polygenic model of the metabolic syndrome with reduced circulating and intra-adipose glucocorticoid action Diabetes 54 3371 8 16306351 10.2337/diabetes.54.12.3371 1:CAS:528:DC%2BD2MXht12gs7bF (Pubitemid 43334325)
34. DE Livingstone GC Jones K Smith, et al. 2000 Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese zucker rats Endocrinology 141 560 3 10650936 10.1210/en.141.2.560 1:CAS:528:DC%2BD3cXmvFClsg%3D%3D (Pubitemid 32250479)
35. R Baudrand CA Carvajal A Riquelme 2010 Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients Obes Surg. 20 77 83 19690925 10.1007/s11695-009-9937-0
36. K Simonyte E Rask I Naslund, et al. 2009 Obesity is accompanied by disturbances in peripheral glucocorticoid metabolism and changes in FA recycling Obesity (Silver Spring). 17 1982 7 10.1038/oby.2009.99 1:CAS:528: DC%2BD1MXhtlWisL3F
37. Y Wang Y Nakagawa L Liu, et al. 2011 Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes Diabetologia 54 440 50 21052977 10.1007/s00125-010-1956-9 1:CAS:528:DC%2BC3MXjtVehtA%3D%3D
38. N Yabaluri MD Bashyam 2010 Hormonal regulation of gluconeogenic gene transcription in the liver J Biosci 35 473 84 20826956 10.1007/s12038-010-0052-0 1:CAS:528:DC%2BC3cXht1eqsLbE
39. P Alberts L Engblom N Edling, et al. 2002 Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice Diabetologia 45 1528 32 12436336 10.1007/s00125-002-0959-6 1:CAS:528:DC%2BD38XoslOrs7s%3D (Pubitemid 35352046)
40. BG Bhat H Younis J Herrera, et al. 2008 Antisense inhibition of 11bhydroxysteroid dehydrogenase type 1 improves diabetes in a novel cortisone-induced diabetic KK mouse model Biochem Biophys Res Com. 365 740 5 18029262 10.1016/j.bbrc.2007.11.032 1:CAS:528:DC%2BD2sXhsVCks7jF (Pubitemid 350234853)
41. DS Edgerton R Basu CJ Ramnanan, et al. 2010 Effect of 11b-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog Am J Physiol Endocrinol Metab 298 E1019 E1026 20159854 10.1152/ajpendo.00740.2009 1:CAS:528:DC%2BC3cXmtlWjt74%3D
42. B Balkau P Valensi E Eschwege, et al. 2007 A review of the metabolic syndrome Diabetes Metab. 3 405 13 10.1016/j.diabet.2007.08.001 (Pubitemid 350213448)
43. J Rosenstock S Banarer VA Fonseca, et al. 2010 The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy Diabetes Care 33 1516 22 20413513 10.2337/dc09-2315 1:CAS:528:DC%2BC3cXpslKhu7s%3D
44. NM Morton 2010 Obesity and corticosteroids: 11b-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease Mol Cell Endocrinol 316 154 64 19804814 10.1016/j.mce.2009.09.024 1:CAS:528:DC%2BD1MXhs1WgtbnK